Xontogeny, LLC

Insider Reports History

Entity
Company
Location
51 Astor Place, 10 Th Floor, New York, NY
Signature
/s/ Christopher Garabedian for Xontogeny, LLC, By: Christoph Garabedian, its Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Xontogeny, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Landos Biopharma, Inc. Director Stock Option (Right to Buy) 10.7K Aug 27, 2021 Indirect

Insider Reports Filed by Xontogeny, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LABP Landos Biopharma, Inc. Aug 27, 2021 1 $0 4 Aug 31, 2021 Director